The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of dynamic changes in serological markers with survival in de novo metastatic hormone-sensitive prostate cancer.
 
Soumyajit Roy
No Relationships to Disclose
 
Amy Trinh Le
No Relationships to Disclose
 
Daniel Eidelberg Spratt
Honoraria - Varian Medical Systems
Consulting or Advisory Role - AstraZeneca; Bayer; Blue Earth Diagnostics; Boston Scientific; Janssen Oncology; Myovant Sciences; Pfizer; Varian Medical Systems
Research Funding - Janssen (Inst)
 
Yilun Sun
No Relationships to Disclose
 
Scott C. Morgan
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen; Tersera
 
Gaurav Marwaha
No Relationships to Disclose
 
Amar Upadhyaya Kishan
Stock and Other Ownership Interests - ViewRay
Honoraria - Varian Medical Systems; ViewRay; ViewRay
Consulting or Advisory Role - Boston Scientific; Janssen
Research Funding - Janssen Oncology (Inst); Point Biopharma (Inst); ViewRay; ViewRay
 
Christopher J.D. Wallis
Honoraria - Bayer; EMD Serono; Haymarket Medical Education; Knight Therapeutics; Tersera; Tolmar
Consulting or Advisory Role - Janssen Oncology; Precision Point Specialty; Sesen Bio
Research Funding - Knight Therapeutics
Travel, Accommodations, Expenses - Tolmar
 
Fred Saad
Honoraria - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; BMS; Janssen Oncology; Knight Therapeutics; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca/MedImmune; Bayer; Janssen Oncology; Knight Therapeutics; Myovant Sciences; Novartis; Pfizer; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
 
Shawn Malone
Honoraria - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Bayer; Janssen; Knight Pharmaceuticals
Travel, Accommodations, Expenses - Sanofi; Tersera